Sars Spike Protein

Mouse Monoclonal Anti-SARS Spike Protein IgG
AB-15710 20 ug
EUR 489.6

Human IgG antibody Laboratories manufactures the sars spike protein reagents distributed by Genprice. The Sars Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Sars products are available in stock. Specificity: Sars Category: Spike Group: Protein

True north Cryobox 5mLBlue
PK10
EUR 153.6

True north Cryobox 15mLNatural
PK10
EUR 212.4

True north Cryobox 15mLBlue
PK10
EUR 212.4

True north Cryobox 50mLNatural
PK10
EUR 210

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

Protein information

SARS Biotinylated Spike RBD Recombinant Protein
10-212 0.1 mg
EUR 752.1
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS Associated Spike Mosaic S(M) Protein
20-abx260155
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

SARS Associated Spike Mosaic S(N) Protein
20-abx260157
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)
P1541-10 10 µg
EUR 211.2

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)
P1541-50 50 µg
EUR 818.4

Recombinant SARS Spike Mosaic Protein S (N-Terminal)
VAng-Lsx0073-inquire inquire Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD)
P1533-10 10 µg
EUR 235.2

Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD)
P1533-50 50 µg
EUR 709.2

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)
P1540-10 10 µg
EUR 211.2

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)
P1540-50 50 µg
EUR 818.4

SARS (IN3) Spike Peptide
3225P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN3) Spike peptide

SARS (IN1) Spike Peptide
3221P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN1) Spike peptide

SARS (IN2) Spike Peptide
3223P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN2) Spike peptide

SARS CoV-2 full length spike protein nanodisc complex
21-817 0.025 mg
EUR 1968
Description: The coronavirus, also known as SARS-CoV-2, enters the cell by using its surface SPIKE. SPIKE is processed on the cell's surface by TMPRSS2, a serine protease. It then subsequently binds to ACE2 a cell surface receptor. The Native SPIKE protein is a trimer that is located in the coronavirus membrane. Therefore to get pure & native SPIKE the trimer needs to be kept intact. Our lab staff achieved this in three different ways: MSP nanodiscs, based on MSP proteins Detergent Mycelles, as you can see here Synthetic nanodiscs

SARS Coronavirus spike (HSZ-Cc) Recombinant Protein
20-219 0.1 mg
EUR 726.9
Description: SARS Coronavirus spike (HSZ-Cc) Recombinant Protein

SARS-CoV Spike Antibody
3225-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.